Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Descrizione del progetto

Modelli di calcolo personalizzati per la diagnosi delle malattie

Le malattie metaboliche ereditarie sono rare e spesso difficili da diagnosticare e gestire. I progressi della genomica, della proteomica e della modellazione computazionale oggi offrono nuove opportunità per personalizzare la diagnosi e il trattamento. Il progetto Recon4IMD, finanziato dall’UE, sfrutta questi strumenti per costruire modelli computazionali specifici per il paziente, integrando dati genomici, trascrittomici, proteomici e metabolomici. Questi modelli saranno addestrati sui dati di 2 000 pazienti diagnosticati e convalidati su casi non diagnosticati. La malattia di Gaucher servirà da esempio per comprendere i meccanismi di gravità della malattia. Verrà inoltre progettato un software di modellazione personalizzata clinicamente accessibile e conforme alle normative, aprendo la strada alla medicina di precisione per le malattie metaboliche rare.

Obiettivo

Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Established academic technology for statistical genomic analysis, deep learning-based prediction of protein structure, and whole-body metabolic network modelling shall be applied to generate personalised computational models, given patient-derived genomic, transcriptomic, proteomic and metabolomic data. To train diagnostic models, a comprehensive clinical team will recruit 1,945 diagnosed patients with a wide variety of IMDs, then validate the clinical utility of personalised computational models on a set of 685 undiagnosed patients. An enhanced human metabolic network reconstruction, especially for lipid metabolism, reaction kinetics and inherited metabolic disease pathways, will increase the predictive capacity of cellular and whole-body metabolic network models. As an exemplar for other IMDs, personalised computational modelling will be used to identify compensatory and aggravating mechanisms that associate with clinical severity in Gaucher disease. The predictive capacity of personalised models will be validated by comparison with additional empirical investigations of protein structure and function as well as metabolomics, tracer-based metabolomics and proteomics of patient-derived in vitro disease models. To maximise the potential for impact, personalised modelling software will be developed to be generally applicable to a broad variety of IMDs, and implemented in a way that is both accessible to clinicians and admissible to regulatory authorities. Sustainability will be promoted by development of a roadmap for a European foundation to aid personalised diagnosis and management of IMDs, informed by broad stakeholder consultation. This is a unique opportunity to realise the potential of personalised computational modelling for a broad set of rare diseases, which is a field where European collaboration is an essential for progress.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-RIA - HORIZON Research and Innovation Actions

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-HLTH-2022-TOOL-12-two-stage

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

UNIVERSITY OF GALWAY
Contributo netto dell'UE
€ 2 694 512,75
Indirizzo
UNIVERSITY ROAD
H91 Galway
Irlanda
Regione
Ireland Northern and Western West
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 2 694 512,75

Partecipanti (36)

Partner (5)